MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2011.12.029

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2012

A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.

Terashima Kazuki, Demizu Yusuke, Hashimoto Naoki, Jin Dongcun, Mima Masayuki, Fujii Osamu, Niwa Yasue, Takatori Kento, Kitajima Naoto, Sirakawa Sachiyo, Yonson Ku, Hishikawa Yoshio, Abe Mitsuyuki, Sasaki Ryohei, Sugimura Kazuro, Murakami Masao

Клиническое исследование I фазыКлиническое исследование II фазыСтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: We conducted the study to assess the feasibility and efficacy of gemcitabine-concurrent proton radiotherapy (GPT) for locally advanced pancreatic cancer (LAPC).

MATERIALS AND

METHODS

Of all 50 patients who participated in the study, 5 patients with gastrointestinal (GI)-adjacent LAPC were enrolled in P-1 (50 Gy equivalent [GyE] in 25 fractions) and 5 patients with non-GI-adjacent LAPC in P-2 (70.2 GyE in 26 fractions), and 40 patients with LAPC regardless of GI-adjacency in P-3 (67.5 GyE in 25 fractions using the field-within-a-field technique). In every protocol, gemcitabine (800 mg/m(2)/week for 3 weeks) was administered concurrently. Every patient received adjuvant chemotherapy including gemcitabine after GPT within the tolerable limit.

RESULTS

The median follow-up period was 12.5 months. The scheduled GPT was feasible for all except 6 patients (12%) due to acute hematologic or GI toxicities. Grade 3 or greater late gastric ulcer and hemorrhage were seen in 5 patients (10%) in P-2 and P-3. The one-year freedom from local-progression, progression-free, and overall survival rates were 81.7%, 64.3%, and 76.8%, respectively.

CONCLUSION

GPT was feasible and showed high efficacy. Although the number of patients and the follow-up periods are insufficient, the clinical results seem very encouraging.

Для цитирования: Terashima Kazuki, Demizu Yusuke, Hashimoto Naoki, Jin Dongcun, Mima Masayuki, Fujii Osamu, Niwa Yasue, Takatori Kento, Kitajima Naoto, Sirakawa Sachiyo, Yonson Ku, Hishikawa Yoshio, Abe Mitsuyuki, Sasaki Ryohei, Sugimura Kazuro, Murakami Masao. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012. DOI: 10.1016/j.radonc.2011.12.029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.